Results 231 to 240 of about 57,705 (278)

Endocrine disruption induced by organotin compounds; organotins function as a powerful agonist for nuclear receptors rather than an aromatase inhibitor

, 2008
Tsuyoshi Nakanishi
openalex   +2 more sources

Efficacy of Dual Hormonal Therapy with Fulvestrant and Aromatase Inhibitors as Neoadjuvant Endocrine Treatment for Locally Advanced Breast Cancer. [PDF]

Cancers (Basel)
Majić A, Bajić Ž, Ban M, Tica Sedlar I, Čerina Pavlinović D, Petrić Miše B, Strikić A, Tomić S, Vrdoljak E.   +8 more
europepmc   +1 more source

Drug-Induced Liver Injury Secondary to Endocrine Therapy With Aromatase Inhibitors: A Case Report. [PDF]

Cureus
Smith NJ, Watchalotone S, Sandhu S.
europepmc   +1 more source

A case of diffuse infiltrative liver metastases of breast cancer with severe jaundice successfully treated with aromatase inhibitor

, 2014
Munefumi Tomomatsu, Masahiro Kishimoto, Hiroya Iida, Shinichi Ikuta, Tsukasa Aihara, Hidenori Yanagi, Ayako Kakuno, Kyoko Ikeuchi, Naoki Yamanaka   +8 more
openalex   +2 more sources

Lesson from a metastatic male breast cancer case: CDK4/6 plus aromatase inhibitors could not exceed tamoxifen. [PDF]

Discov Oncol
Najdi T, Seif S, Damaj N, Kattan J.
europepmc   +1 more source

Uso de inibidores da aromatase no tratamento do câncer de mama e osteoporose = The use of aromatase inhibitors for breast cancer treatment and osteoporosis

, 2005
Lina Barbosa Cassol, Bernardo Garicochea
openalex   +1 more source

Plasma Proteomics and Metabolomics of Aromatase Inhibitors-Related Musculoskeletal Syndrome in Early Breast Cancer Patients. [PDF]

Metabolites
Jing F, Jiang L, Cao Y, Tian M, Qiu J, Zhang J, Tang L, Lu R, Hu Y.   +8 more
europepmc   +1 more source

Dementia and Alzheimer's Disease Associated With Aromatase Inhibitors: A Disproportionality Analysis of the WHO Pharmacovigilance Database (VigiBase). [PDF]

Pharmacol Res Perspect
Yuste MT, Sainz-Gil M, Escudero E, Marín P.   +3 more
europepmc   +1 more source

Aromatase inhibitors therapy and major osteoporotic fracture risk in postmenopausal breast cancer patients: a nationwide real-world cohort study. [PDF]

Breast Cancer Res
Liu PH, Tsai CF, Hsu YC, Wu CY, Yang HY.
europepmc   +1 more source

Niraparib Plus Aromatase Inhibitors for Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with a Germline <i>BRCA</i> Mutation. [PDF]

Cancers (Basel)
Lema L, Pérez-García JM, Blanch S, Balmaña J, García-Sáenz JÁ, Vegas EF, Jiménez B, de la Haba J, Campolier M, Shimizu E, Alcalá-López D, Sampayo-Cordero M, Cortés J, Llombart-Cussac A.   +13 more
europepmc   +1 more source